At its monthly breakfast meeting on Tuesday, May 11th, 2021, Beacon Angels members entertained the following presenters:
- Octagon Therapeutics, which is developing precision immunomodulators for chronic autoimmune diseasethat specifically target immune dysregulation; and
- Genomic Expressions, which offers OneRNA,® a disease agnostic exponentially scalable RNA analysis platform to detect disease, monitor health and design next-generation cures.
Members reported on companies in due diligence consisting of:
- Yarn Corporation; and
- AOA Diagnostics.
We heard updates on the funding rounds of Cognoptix, GelMEDIX, RevBio and Xeno Biosciences.
Beacon Angels members delivered portfolio company updates.